Balyasny Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-51,815
| Closed | -$803K | – | 2004 |
|
|
2024
Q2 | $803K | Buy |
+51,815
| New | +$803K | ﹤0.01% | 1301 |
|
|
2024
Q1 | – | Sell |
-57,467
| Closed | -$966K | – | 2053 |
|
|
2023
Q4 | $966K | Buy |
+57,467
| New | +$966K | ﹤0.01% | 1220 |
|
|
2022
Q4 | – | Sell |
-34,516
| Closed | -$443K | – | 2382 |
|
|
2022
Q3 | $443K | Buy |
+34,516
| New | +$443K | ﹤0.01% | 1610 |
|
|
2018
Q2 | – | Sell |
-40,710
| Closed | -$97K | – | 1634 |
|
|
2018
Q1 | $97K | Buy |
+40,710
| New | +$97K | ﹤0.01% | 1643 |
|
|
2017
Q4 | – | Sell |
-14,800
| Closed | -$37K | – | 1829 |
|
|
2017
Q3 | $37K | Buy |
+14,800
| New | +$37K | ﹤0.01% | 1617 |
|